Back to top


The following newer oral anticoagulants are available in Australia.

  • Rivaroxaban (Xarelto®)
  • Dabigatran (Pradaxa®)
  • Apixaban (Eliquis®)

Patients may be initiated on these agents whilst in hospital or in the community for a number of indications.

For a broad overview of these medications, which are now in regular use, please read the NSW Health Safety Notice Newer Oral Anticoagulants, Clinical Safety Quality and Governance Branch, November 2011. Patients may present with overdose, bleeding or with no specific complications.

For a more detailed look at each of the NOACs please click on the link below. Please note: some of the information provided is sourced from the suppliers.

Further References and Resources

Find here a set of papers and online posts from various authors discussing important practice changes or potential changes:

© Agency for Clinical Innovation 2023